Quick Answer
Praxis Precision Medicines, Inc. reported Operating Income of -$326.20 million for fiscal year 2025.
Praxis Precision Medicines, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$326.20M | -63.0% |
| 2024 | -$200.16M | -58.4% |
| 2023 | -$126.37M | +41.2% |
| 2022 | -$214.99M | -28.5% |
| 2021 | -$167.33M | -170.0% |
| 2020 | -$61.97M | -73.1% |
| 2019 | -$35.79M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$78.36M | -37.9% | -3.0% |
| June 30, 2025 | -$76.07M | -102.9% | -1.8% |
| March 31, 2025 | -$74.73M | -78.4% | -31.5% |
| September 30, 2024 | -$56.84M | -122.7% | -51.6% |
| June 30, 2024 | -$37.49M | -7.2% | +10.5% |
| March 31, 2024 | -$41.89M | -10.0% | -64.2% |
| September 30, 2023 | -$25.52M | +42.4% | +27.0% |
| June 30, 2023 | -$34.96M | +42.1% | +8.2% |
- Praxis Precision Medicines, Inc. showed a decrease of -63.0% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Praxis Precision Medicines, Inc.’s operating income has declined by 811.4% (from -$35.79 million to -$326.20 million).
- The most recent figure is from Praxis Precision Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: